AROCELL AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.391 SEK | -6.46% |
|
-10.11% | -10.53% |
| 03/05 | AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 18/04 | Swedish Diagnostics Company AroCell Secures US Patent | MT |
Chart calendar AroCell AB
dee3d6f0473fd4147.sENJs_oIfsBH1A_4EqHbYAehNy0ow6Kd9FuszKwIF8s.xwIzyoo-NYJys0O6cO2rNVKWdX1YkPTc2SrPndhafK_CIWTUuGlGghWnYA~c2e526fd32de7cecc77009ac36816461
Upcoming events on AroCell AB
Past events on AroCell AB
| 03/05/2024 | Q1 2024 Earnings Release |
| 22/02/2024 | Q4 2023 Earnings Release |
| 24/01/2024 06:51 pm | Redeye Theme: Fight Cancer |
| 25/10/2023 | Q3 2023 Earnings Release |
| 23/08/2023 | Q2 2023 Earnings Release |
| 24/05/2023 | Annual General Meeting |
| 10/05/2023 | Redeye Medtech Forum |
| 28/04/2023 | Q1 2023 Earnings Release |
| 23/02/2023 | FY 2022 Earnings Release |
| 29/11/2022 | BioStock Life Science Fall Summit 2022 |
| 22/11/2022 | Strategy Update Call |
| 11/11/2022 | Q3 2022 Earnings Release |
| 17/08/2022 | Interim 2022 Earnings Release |
| 24/05/2022 | Annual General Meeting |
| 18/05/2022 | Q1 2022 Earnings Release |
| 24/02/2022 | FY 2021 Earnings Release |
| 12/11/2021 | Q3 2021 Earnings Release |
| 20/08/2021 | Interim 2021 Earnings Release |
| 13/05/2021 | Q1 2021 Earnings Release |
| 06/05/2021 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,44 0,50 -11.4% | 0,00 | 12,0 23,0 -47.84% | 37,0 35,0 5.67% | 43,0 45,1 -4.57% | 58,4 |
|
EBITDA Million SEK | Released Forecast Spread | -17,3 -22,0 21.2% | 0,00 | -26,0 -32,0 18.78% | -14,3 -12,0 -18.76% | -14,2 -13,1 -8.75% | -3,50 |
|
EBIT Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | 0,00 | -50,6 -56,0 9.69% | -59,3 -56,0 -5.9% | -59,8 -57,4 -4.15% | -47,7 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | 0,00 | 0,00 0,00 - | -59,0 -56,0 -5.31% | -59,3 -57,0 -4.03% | -46,0 |
|
Net income Million SEK | Released Forecast Spread | -20,7 -22,0 5.75% | -24,1 | 0,00 0,00 - | -59,0 -56,0 -5.31% | -59,3 -57,0 -4.03% | -46,0 |
|
EPS SEK | Released Forecast Spread | -0,53 -0,29 -82.76% | -0,33 | 0,00 0,00 - | -0,28 -0,50 44% | -0,26 -0,20 -30% | -0,20 |
| Announcement Date | 21/02/20 | 19/02/21 | 07/04/22 | 23/02/23 | 12/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 7,77 6,50 19.54% | 6,35 8,10 -21.62% | 10,4 7,70 35.08% | 12,5 10,7 16.55% | 11,1 13,1 -15.63% | 11,8 12,8 -8.01% | 10,7 13,3 -19.55% | 9,51 11,6 -18.01% | 12,8 12,3 4.09% | 13,6 | 15,2 | 16,8 | 17,1 |
|
EBITDA Million SEK | Released Forecast Spread | -10,6 -8,10 -31.11% | -10,9 5,80 -288.62% | -5,99 -4,50 -33.11% | -2,30 | -1,30 | -3,40 | -3,50 | -3,90 | -3,20 | -2,10 | -1,10 | -0,50 | -0,20 |
|
EBIT Million SEK | Released Forecast Spread | -15,7 -19,1 17.83% | -16,0 -17,0 5.8% | -11,1 -15,7 29.5% | -16,5 -13,4 -23.34% | -13,7 -12,4 -10.24% | -15,5 -14,5 -6.79% | -13,3 -14,6 9.14% | -17,4 -14,9 -16.54% | -10,8 -14,3 24.66% | -13,2 | -12,2 | -11,6 | -11,3 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -15,7 -19,1 17.83% | -16,0 -17,0 5.79% | |||||||||||
|
Net income Million SEK | Released Forecast Spread | -15,5 -19,1 18.92% | -15,9 -17,0 6.48% | |||||||||||
| Announcement Date | 29/04/22 | 17/08/22 | 27/10/22 | 23/02/23 | 03/05/23 | 23/08/23 | 02/11/23 | 12/04/24 | 03/05/24 | - | - | - | - |
| 16/05/2024 | REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected) |
| 17/05/2024 11:30 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 21/05/2024 | ALVOTECH: Q1 2024 Earnings Release |
| 22/05/2024 | CUREVAC N.V.: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EXSCIENTIA PLC: Q1 2024 Earnings Release (Projected) |
| 22/05/2024 | EVOTEC SE: Q1 2024 Earnings Release |
| 01/07/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 15/07/2024 11:15 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 22/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
Past sector events for AroCell AB
| Today | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 14/05/2024 05:00 pm | ABSCI CORPORATION: Q1 2024 Earnings Release |
| 14/05/2024 | BELITE BIO, INC: Q1 2024 Earnings Release |
| 14/05/2024 | POLARIS GROUP: Q1 2024 Earnings Release |
| 14/05/2024 02:00 am | AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 04:30 pm | APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 13/05/2024 04:30 am | PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release |
| 13/05/2024 04:00 pm | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 14/05/2024 01:40 am | CENTESSA PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 13/05/2024 | BIOMEA FUSION, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AROC Stock
- Calendar AroCell AB
